Consistent Effects of Canagliflozin (CANA) Across Racial Subgroups of Patients with Type 2 Diabetes Mellitus (T2DM)

被引：0

|

作者：

Gavin, James R., III

Davies, Melanie J.

Davies, Michael

Vija-Purkar, Ujjwala

Alba, Maria

机构：

来源：

DIABETES | 2014年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1095-P

引用

收藏

页码：A285 / A285

页数：1

相关论文

共 50 条

[1] Blood Pressure (BP) Effects of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Pfeifer, Michael
Townsend, Raymond
Davies, Michael J.
Vijapurkar, Ujjwala
Ren, Jimmy
DIABETES, 2016, 65 : A303 - A303
[2] Effects of Canagliflozin (CANA) on Biomarkers of Cardiovascular (CV) Stress in Older Patients with Type 2 Diabetes Mellitus (T2DM)
Januzzi, James L.
Butler, Javed
Jarolim, Petr
Sattar, Naveed
Vijapurkar, Ujjwala
Merton, Katherine W.
Ren, Jimmy
Canovatchel, William
Desai, Mehul
Davies, Michael J.
DIABETES, 2017, 66 : LB40 - LB40
[3] Genital Mycotic Infections With Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM)
Nyirjesy, Paul
Sobel, Jack
Fung, Albert
Gassmann-Mayer, Cristiana
Ways, Kirk
Usiskin, Keith
DIABETES, 2013, 62 : A276 - A276
[4] Achievement of Diabetes-related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Blonde, Lawrence
Woo, Vincent
Mathieu, Chantal
Yee, Jacqueline
Vijapurkar, Ujjwala
Meininger, Gary
DIABETES, 2014, 63 : A284 - A284
[5] Effect of Canagliflozin (CANA) on Liver Function Tests (LFTs) in Patients with Type 2 Diabetes Mellitus (T2DM)
Usiskin, Keith
Leiter, Lawrence A.
Forst, Thomas
Polidori, David
Xie, John
Sha, Sue
DIABETES, 2014, 63 : A284 - A284
[6] Pharmacokinetics (PK) and Pharmacodynamics (PD) of Canagliflozin (CANA) in Pediatric Patients with Type 2 Diabetes Mellitus (T2DM)
Tamborlane, William
Polidori, David
Di Prospero, Nicolas
DIABETES, 2017, 66 : A371 - A371
[7] Canagliflozin (CANA) Reduces Serum Uric Acid (SUA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Davies, Michael
Trujillo, Angelina
Vijapurkar, Ujjwala
Damara-Ju, C. V.
Meininger, Gary
DIABETES, 2014, 63 : A283 - A284
[8] Urinary Tract Infection (UTI) With Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM)
Nicolle, Lindsay E.
Capuano, George
Fung, Albert
Usiskin, Keith
DIABETES, 2013, 62 : A296 - A296
[9] Lower Blood Pressure (BP) With Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM)
Weir, Matthew R.
Januszewicz, Andrzej
Gilbert, Richard
Gonzalez, Fernando Lavalle
Meininger, Gary
DIABETES, 2013, 62 : A278 - A278
[10] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
Martin, Silas C.
Henk, Henry J.
Chow, Wing
DIABETES, 2014, 63 : A307 - A307

← 1 2 3 4 5 →